Chen, A. CD19 And CD22 Dual-Target CAR-T Therapy Via CRISPR Cas9 Engineering for Relapsed B-Cell Acute Lymphoblastic Leukemia. AJST 2025, 18 (1), 621-625. https://doi.org/10.54097/79zwp242.